These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28061438)

  • 41. Mir-139 Regulates Autophagy in Prostate Cancer Cells Through Beclin-1 and mTOR Signaling Proteins.
    Nam RK; Benatar T; Amemiya Y; Sherman C; Seth A
    Anticancer Res; 2020 Dec; 40(12):6649-6663. PubMed ID: 33288559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of ID2 antagonizes arsenic trioxide-induced antitumor effects in cancer cells.
    Zhang X; Lv C; Du B; Ma X; Guan J; Gao S; Li X; Zheng L; Lei L
    Tumori; 2014; 100(3):352-7. PubMed ID: 25076250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
    Lam SK; Mak JC; Zheng CY; Li YY; Kwong YL; Ho JC
    Int J Oncol; 2014 Jun; 44(6):2093-102. PubMed ID: 24691991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
    Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
    Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death.
    Alonso MM; Jiang H; Yokoyama T; Xu J; Bekele NB; Lang FF; Kondo S; Gomez-Manzano C; Fueyo J
    Mol Ther; 2008 Mar; 16(3):487-93. PubMed ID: 18253154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors.
    Wu EJ; Goussetis DJ; Beauchamp E; Kosciuczuk EM; Altman JK; Eklund EA; Platanias LC
    Cancer Biol Ther; 2014 Apr; 15(4):473-8. PubMed ID: 24496081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
    Gatti L; Cossa G; Tinelli S; Carenini N; Arrighetti N; Pennati M; Cominetti D; De Cesare M; Zunino F; Zaffaroni N; Perego P
    J Pharmacol Exp Ther; 2014 Mar; 348(3):360-71. PubMed ID: 24345465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
    You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
    PLoS One; 2015; 10(9):e0137589. PubMed ID: 26352139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
    Kumar D; Shankar S; Srivastava RK
    Cancer Lett; 2014 Feb; 343(2):179-89. PubMed ID: 24125861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
    Cheng B; Yang X; Han Z; An L; Liu S
    Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
    Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
    Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
    Lu J; Jin J
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Song J; Zhao Z; Fan X; Chen M; Cheng X; Zhang D; Wu F; Ying X; Ji J
    Oncotarget; 2016 Oct; 7(43):70504-70515. PubMed ID: 27655700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. F-box protein FBXO41 plays vital role in arsenic trioxide-mediated autophagic death of cancer cells.
    Agrawal Y; Nadkarni KS; Gupta NA; Manne RK; Santra MK
    Toxicol Appl Pharmacol; 2022 Apr; 441():115973. PubMed ID: 35278439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.
    Cavaliere V; Lombardo T; Costantino SN; Kornblihtt L; Alvarez EM; Blanco GA
    Eur J Cancer; 2014 Dec; 50(18):3243-61. PubMed ID: 25446377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of arsenic trioxide on the cerulein-induced AR42J cells and its gene regulation.
    Xue D; Zhang W; Liang T; Zhao S; Sun B; Sun D
    Pancreas; 2009 Oct; 38(7):e183-9. PubMed ID: 19730151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
    Oncotarget; 2016 Dec; 7(50):83359-83377. PubMed ID: 27829220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.
    Shen P; Jiang T; Lu H; Han H; Luo R
    Cell Biol Int; 2011 Aug; 35(8):803-10. PubMed ID: 21418039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.
    Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.